Literature DB >> 23531935

Reversible dementia and gait disturbance as a result of polypharmacy.

Monica Gupta1, Ram Singh, Kamal Singh, S S Lehl.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23531935      PMCID： PMC3618831          DOI： 10.1136/bcr-2013-008932

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Hydrocephalus during natalizumab treatment.

Authors:  Chiara Zecca; Claudio Städler; Claudio Gobbi
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

2.  Development of communicating hydrocephalus after infliximab infusion.

Authors:  Andrew Maclennan; Millie D Long; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

3.  Reversible dementia and gait disturbance after prolonged use of valproic acid.

Authors:  Matthew D Evans; Ron Shinar; Roy Yaari
Journal:  Seizure       Date:  2011-03-23       Impact factor: 3.184
  3 in total
  2 in total

1.  The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.

Authors:  Hae-Young Park; Ji-Won Park; Hong Ji Song; Hyun Soon Sohn; Jin-Won Kwon
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

2.  Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report.

Authors:  Jussi Valtonen; Mira Karrasch
Journal:  Ther Adv Psychopharmacol       Date:  2020-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.